GENTAUR Belgium BVBA BE0473327336
Voortstraat 49, 1910 Kampenhout BELGIUM
Tel 0032 16 58 90 45
GENTAUR U.S.A Genprice Inc 6017 Snell Ave, Ste 357, SanJose, CA 95123
Tel (408) 780-0908, Fax (408) 780-0908, email@example.com
Index / US Biomax / Rectum cancer tissue array, including TNM, clinical stage and pathology grade, 75 cases_150 cores; ihc Anti-Actin confirmed / Product Detail : RE1503 Rectum cancer tissue array, including TNM, clinical stage and pathology grade, 75 cases_150 cores; ihc Anti-Actin confirmed
#RE1503 Rectum cancer tissue array, including TNM, clinical stage and pathology grade, 75 cases_150 cores; ihc Anti-Actin confirmed
Product name : Rectum cancer tissue array, including TNM, clinical stage and pathology grade, 75 cases_150 cores; ihc Anti-Actin confirmed
Catalog number : RE1503
Supplier name : US Biomax
Data sheet: Ask more or other datasheet now !
About this Product :Rectum cancer tissue array, including TNM, clinical stage and pathology grade, 75 cases_150 cores; ihc Anti-Actin confirmed antibody storage GENTAUR recommends for long therm storage to freeze at -24 C. For short time storage up to 30 days we suggest fridge storage at 1 to 10 C. Prevent multiple freeze taw cycles of Rectum cancer tissue array, including TNM, clinical stage and pathology grade, 75 cases_150 cores; ihc Anti-Actin confirmed.
Rectum cancer tissue array, including TNM, clinical stage and pathology grade, 75 cases_150 cores; ihc Anti-Actin confirmed storing antibdies for longer storage periods of the Rectum cancer tissue array, including TNM, clinical stage and pathology grade, 75 cases_150 cores; ihc Anti-Actin confirmed we recommend - 21C or lower and for short periods lees than 1 month we suggest +5C fridge temperatures.
More Details about
|Microarray Panel:||Rectum adenocarcinoma tissue microarray, containing 63 cases of rectum adenocarcinoma, 4 rectum mucinous adenocarcinoma, 1 each of rectum signet-ring cell carcinoma, squamous cell carcinoma and undifferentiated carcinoma, plus 3 rectum adenoma and 2 normal rectum tissue, duplicate cores per case|
|Layout:||15 cols × 10 rows|
|Core Diameter:||1 mm|
|Quality Control:||Anti-Actin confirmed|
|Applications:||Routine histology procedures including ImmunoHistochemistry (IHC) and In Situ Hybridization (ISH), protocols which can be found on our support page.|
|Notes:||Unless specified, all TMA slides are not coated with extra layer of paraffin (tissue cores can be easily seen on the glass), so there is no need to bake, can be directly put into xylene for de-paraffin procedure.|
*Tissue Microarray Slide Types:
- Unstained: unstained paraffin tissue microarray slide.
- Trial: tissue microarray trial slide. 10% - 25% of cores missing. Good for titrating antibody dilution and experiment conditions. Limited numbers are available, to 2 per item per order. Test slides (tissue arrays with catalog numbers ending with 241 or 242) are recommended as a substitute.
- H & E: Hematoxylin and Eosin stained tissue microarray slide.
Contact us about this product :
Our team will respond you as soon as possible !
We have also other products like : Rectum cancer tissue array, including TNM, clinical stage and pathology grade, 75 cases_150 cores; ihc Anti-Actin confirmed
52062 Aachen Deutschland
Support Karolina Elandt
Fax: (+49) 241 56 00 47 88
Logistic :0241 40 08 90 86
IBAN lautet DE8839050000107569353
Handelsregister Aachen HR B 16058
Umsatzsteuer-Identifikationsnummer *** DE 815175831
firstname.lastname@example.org | Gentaur
Genprice Inc, Logistics
547, Yurok Circle
San Jose, CA 95123
Tel (408) 780-0908,
Fax (408) 780-0908,
Genprice Inc, Invoices and accounting
6017 Snell Ave, Ste 357
San Jose, CA 95123
Canada Montreal +15149077481
Ceská republika Praha +420246019719
Finland Helsset +358942419041
Magyarország Budapest +3619980547
US New York+17185132983
WP1019: FAS pathway and Stress induction of HSP regulation
WP1062: Regulation of Actin Cytoskeleton
WP1138: FAS pathway and Stress induction of HSP regulation
WP1178: Regulation of Actin Cytoskeleton
WP1380: Regulation of Actin Cytoskeleton
WP1589: Folate-Alcohol and Cancer Pathway
WP1963: The effect of Glucocorticoids on target gene expression
WP1968: genetic alternations of lung cancer
WP1971: Integrated Cancer pathway
WP1984: Integrated Breast Cancer Pathway
WP2107: pathways in human cancer
WP2256: Integrated Pancreatic Cancer Pathway
WP2263: Prostate Cancer
WP2272: Pathogenic Escherichia coli infection
WP2291: Deregulation of Rab and Rab Effector Genes in Bladder Cancer
WP2292: Chemokine signaling pathway
WP2335: sGC Cancer
WP2361: Gastric cancer network 1
WP2363: Gastric cancer network 2
WP2367: Private Pancreatic Cancer
WP2377: Integrated Pancreatic Cancer Pathway
WP2411: Cancer prevention Q
WP2429: Cancer prevention Q
WP314: FAS pathway and Stress induction of HSP regulation
WP351: Regulation of Actin Cytoskeleton
Related Genes :
[CTNNB1 CTNNB OK/SW-cl.35 PRO2286] Catenin beta-1 (Beta-catenin)
[AKT1 PKB RAC] RAC-alpha serine/threonine-protein kinase (EC 188.8.131.52) (Protein kinase B) (PKB) (Protein kinase B alpha) (PKB alpha) (Proto-oncogene c-Akt) (RAC-PK-alpha)
[SDCBP MDA9 SYCL] Syntenin-1 (Melanoma differentiation-associated protein 9) (MDA-9) (Pro-TGF-alpha cytoplasmic domain-interacting protein 18) (TACIP18) (Scaffold protein Pbp1) (Syndecan-binding protein 1)
[SMAD3 MADH3] Mothers against decapentaplegic homolog 3 (MAD homolog 3) (Mad3) (Mothers against DPP homolog 3) (hMAD-3) (JV15-2) (SMAD family member 3) (SMAD 3) (Smad3) (hSMAD3)
[MLH1 COCA2] DNA mismatch repair protein Mlh1 (MutL protein homolog 1)
[RET CDHF12 CDHR16 PTC RET51] Proto-oncogene tyrosine-protein kinase receptor Ret (EC 184.108.40.206) (Cadherin family member 12) (Proto-oncogene c-Ret) [Cleaved into: Soluble RET kinase fragment; Extracellular cell-membrane anchored RET cadherin 120 kDa fragment]
[MSH2] DNA mismatch repair protein Msh2 (hMSH2) (MutS protein homolog 2)
[NFKB1] Nuclear factor NF-kappa-B p105 subunit (DNA-binding factor KBF1) (EBP-1) (Nuclear factor of kappa light polypeptide gene enhancer in B-cells 1) [Cleaved into: Nuclear factor NF-kappa-B p50 subunit]
[NF1] Neurofibromin (Neurofibromatosis-related protein NF-1) [Cleaved into: Neurofibromin truncated]
[SMAD4 DPC4 MADH4] Mothers against decapentaplegic homolog 4 (MAD homolog 4) (Mothers against DPP homolog 4) (Deletion target in pancreatic carcinoma 4) (SMAD family member 4) (SMAD 4) (Smad4) (hSMAD4)
[WRN RECQ3 RECQL2] Werner syndrome ATP-dependent helicase (EC 220.127.116.11) (DNA helicase, RecQ-like type 3) (RecQ3) (Exonuclease WRN) (EC 3.1.-.-) (RecQ protein-like 2)
[BRAF BRAF1 RAFB1] Serine/threonine-protein kinase B-raf (EC 18.104.22.168) (Proto-oncogene B-Raf) (p94) (v-Raf murine sarcoma viral oncogene homolog B1)
[APC DP2.5] Adenomatous polyposis coli protein (Protein APC) (Deleted in polyposis 2.5)
[PIK3CA] Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform (PI3-kinase subunit alpha) (PI3K-alpha) (PI3Kalpha) (PtdIns-3-kinase subunit alpha) (EC 22.214.171.124) (Phosphatidylinositol 4,5-bisphosphate 3-kinase 110 kDa catalytic subunit alpha) (PtdIns-3-kinase subunit p110-alpha) (p110alpha) (Phosphoinositide-3-kinase catalytic alpha polypeptide) (Serine/threonine protein kinase PIK3CA) (EC 126.96.36.199)
[SMAD7 MADH7 MADH8] Mothers against decapentaplegic homolog 7 (MAD homolog 7) (Mothers against DPP homolog 7) (Mothers against decapentaplegic homolog 8) (MAD homolog 8) (Mothers against DPP homolog 8) (SMAD family member 7) (SMAD 7) (Smad7) (hSMAD7)
[MSH6 GTBP] DNA mismatch repair protein Msh6 (hMSH6) (G/T mismatch-binding protein) (GTBP) (GTMBP) (MutS protein homolog 6) (MutS-alpha 160 kDa subunit) (p160)
[ALOX12 12LO LOG12] Arachidonate 12-lipoxygenase, 12S-type (12S-LOX) (12S-lipoxygenase) (EC 188.8.131.52) (Lipoxin synthase 12-LO) (EC 3.3.2.-) (Platelet-type lipoxygenase 12)
[MCRS1 INO80Q MSP58] Microspherule protein 1 (58 kDa microspherule protein) (Cell cycle-regulated factor p78) (INO80 complex subunit J) (MCRS2)
[POLD1 POLD] DNA polymerase delta catalytic subunit (EC 184.108.40.206) (EC 3.1.11.-) (DNA polymerase subunit delta p125)
[CDK5RAP3 IC53 LZAP MSTP016 OK/SW-cl.114 PP1553] CDK5 regulatory subunit-associated protein 3 (CDK5 activator-binding protein C53) (LXXLL/leucine-zipper-containing ARF-binding protein) (Protein HSF-27)
[EPHA3 ETK ETK1 HEK TYRO4] Ephrin type-A receptor 3 (EC 220.127.116.11) (EPH-like kinase 4) (EK4) (hEK4) (HEK) (Human embryo kinase) (Tyrosine-protein kinase TYRO4) (Tyrosine-protein kinase receptor ETK1) (Eph-like tyrosine kinase 1)
[MTHFD1 MTHFC MTHFD] C-1-tetrahydrofolate synthase, cytoplasmic (C1-THF synthase) [Cleaved into: C-1-tetrahydrofolate synthase, cytoplasmic, N-terminally processed] [Includes: Methylenetetrahydrofolate dehydrogenase (EC 18.104.22.168); Methenyltetrahydrofolate cyclohydrolase (EC 22.214.171.124); Formyltetrahydrofolate synthetase (EC 126.96.36.199)]
[RNF40 BRE1B KIAA0661] E3 ubiquitin-protein ligase BRE1B (BRE1-B) (EC 188.8.131.52) (95 kDa retinoblastoma-associated protein) (RBP95) (RING finger protein 40) (RING-type E3 ubiquitin transferase BRE1B)
[PRAC1 C17orf92 PRAC] Small nuclear protein PRAC1 (Prostate cancer susceptibility candidate protein 1) (Prostate, rectum and colon expressed gene protein)
[POLE POLE1] DNA polymerase epsilon catalytic subunit A (EC 184.108.40.206) (DNA polymerase II subunit A)
[PRAC2 C17orf93 HOXB-AS5 HOXB13-AS1 NCRNA00253] Putative protein PRAC2 (Prostate, rectum and colon expressed gene protein 2)
[PAXIP1 PAXIP1L PTIP CAGF28] PAX-interacting protein 1 (PAX transactivation activation domain-interacting protein)
[AXIN2] Axin-2 (Axin-like protein) (Axil) (Axis inhibition protein 2) (Conductin)
[ATG9A APG9L1] Autophagy-related protein 9A (APG9-like 1) (mATG9)
[VAV2] Guanine nucleotide exchange factor VAV2 (VAV-2)
 Metformin use and the risk of colorectal adenoma: A systematic review and meta-analysis.
 Gastrointestinal: Enema nozzle injury to the rectum, a vague presentation with significant morbidity.
 Primary tumor sidedness has an impact on prognosis and treatment outcome in metastatic colorectal cancer: results from two randomized first-line panitumumab studies.
 Dosimetric advantages of a clinical daily adaptive plan selection strategy compared with a non-adaptive strategy in cervical cancer radiation therapy.
 The influence of different muscle mass measurements on the diagnosis of cancer cachexia.
 Dose gradient based algorithm for beam weights selection in 3D-CRT plans.
 Metastatic breast cancer to the rectum: A case report with emphasis on MRI features.
 Spatial features of dose-surface maps from deformably-registered plans correlate with late gastrointestinal complications.
 Waiting times for cancer patients in Sweden: A nationwide population-based study.
 An evaluation of two different methods of coccygectomy in patients with traumatic coccydynia.
Enter catalog number :